Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Acetazolamide (acetazolamide systemic) is a member of the following drug classes: carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors and is used to treat Edema, Epilepsy, Glaucoma, Hydrocephalus, Hypokalemic Periodic Paralysis, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri and Seizure Prevention.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Carbonic anhydrase inhibitor

Diuretic agent

Glaucoma treatment

Chemical Names

N-(5-Sulfamoyl-1,3,4-tiadiazol-2-yl)acetamide (BAN, JAN)

2-Acetamido-1,3,4-tiadiazole-5-sulfonamide (WHO)

Foreign Names

Generic Names

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.